MVMD is focused on the differentiation of delivery science and the consumer value propositions necessary to create leading health and wellness products that are sought out globally.


Mountain Valley MD has submitted its application to the CSE and is anticipating going public late January, 2020. Follow our story under CSE: MVMD.
If you are interested in investing in our company, or if you would like to discuss a potential partnership or acquisition, we would love to talk to you.


Strategy Highlights

Unprecedented Demand

We are positioned to capitalize on the surge in global medical cannabis demand which is being fueled by liberalized laws that are creating unprecedented shifts in consumer attitudes and access to legal marijuana.

Global Ecosystem

Our focus on strategic partnerships in key markets enables us to leverage intellectual property, establish supply agreements and scale rapidly to meet market demand.

Health & Wellness

We are working against leading consumer propositions that offer increased bioavailability with rapid onset across the $4.2 trillion health and wellness industry.

Management Team

Our management team brings together world-class leadership across growth sciences, cultivation, extraction, marketing and financial services.

Delivery Sciences

MVMD’s advanced desiccated liposome formulations provide transmucosal delivery benefits across leading application categories, including pain management, energy, focus, weight management, sleep, anxiety, and more.

Leading-edge investments

Across our strain genetics, cultivation, extraction and delivery sciences, MVMD prioritizes investment opportunities on disruptive technologies for health and wellness applications.


Subscribe for Updates

Stay plugged in on everything Mountain Valley MD.

Please check your inbox to confirm your subscription.
Oops! Something went wrong while submitting the form.
*By Clicking "Sign Up" You agree to Mountain Valley MD's Privacy Policy